Chrome Extension
WeChat Mini Program
Use on ChatGLM

90-Yttrium-ibritumomab Tiuxetan As First-Line Treatment for Follicular Lymphoma: Updated Efficacy and Safety Results at an Extended Median Follow-Up of 9.6 Years

Annals of Hematology(2022)

Cited 6|Views25
Key words
Follicular lymphoma,First-line therapy,90-yttrium-ibritumomab tiuxetan,90Y-IT
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined